Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (1) Bunse, Mario Dr. (1) Ciraolo, Elisa Dr. (1) Daumke, Oliver Prof. Dr. (1) Gavvovidis, Ioannis Dr. (1) Hinz, Michael Dr. (1) Höpken, Uta Elisabeth PD Dr. (2) Joedicke, Jara Dr. (1) Keller, Ulrich Dr. med. (2) Kettenmann, Helmut Prof. Dr. (1) Kopp, Joachim Dr. (1) Leisegang, Matthias Dr. (4) Lorenz, Felix Dr. (1) Na, Il-Kang Dr. (2) Nguyen, Tam Hoai Dr. (1) Obenaus, Matthias (1) Obermayer, Benedikt Dr. (1) Pezzutto, Antonio Prof. Dr. (17) Rehm, Armin Dr. (1) Rhein, Simone Dr. (1) Uckert, Wolfgang Prof. Dr. (14) Willimsky, Gerald Dr. (1) Wirges, Anthea Dr. (1) Yilmaz, Zekiye Buket Dr. (1) Zschummel, Maria (1) (-) Blankenstein, Thomas Prof. Dr. (7) (-) Ivics, Zoltan Dr. (1) (-) Müller, Gerd Dr. (1) (-) 1997 (2) 1998 (4) 1999 (1) 2000 (4) 2003 (4) 2004 (2) 2005 (5) 2006 (2) 2007 (2) (-) 2008 (1) 2010 (2) 2011 (3) 2013 (1) 2014 (1) (-) 2015 (4) 2016 (2) 2017 (1) 2018 (1) 2019 (2) (-) 2021 (2) Bioinformatics (1) Biology of Malignant Lymphomas (12) Immune Dysregulations in Oncology (1) Mechanism-based Cancer Therapies (1) Mechanisms of Leukemogenesis (1) Microenvironmental Regulation in Autoimmunity and Cancer (2) Mobile DNA (9) (-) Molecular Cell Biology and Gene Therapy (4) Molecular Immunology and Gene Therapy (21) (-) Molecular Immunotherapy (5) Signal Transduction in Tumor Cells (1) Structural Biology of Membrane-Associated Processes (1) Systems Biology of Gene Regulatory Elements (2) Translational Oncology of Solid Tumors (2) 9 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Ivics, Zoltan Dr.Müller, Gerd Dr.Molecular Cell Biology and Gene TherapyMolecular Immunotherapy1997200820152021 Sort: Result score Newest to oldest Oldest to newest October 18, 2021 in Hum Gene Ther Gene therapy "Made in Germany": a historical perspective, analysis of the status quo, and recommendations for action by the German Society for Gene Therapy H. Büning B. Fehse Z. Ivics S. Kochanek U. Koehl C. Kupatt C. Mussolino D.M. Nettelbeck A. Schambach W. Uckert E. Wagner T. Cathomen June 15, 2021 in Int J Cancer Long-term in vitro expansion ensures increased yield of central memory T cells as perspective for manufacturing challenges S. Herda A. Heimann B. Obermayer E. Ciraolo S. Althoff J. Ruß C. Grunert A. Busse L. Bullinger A. Pezzutto T. Blankenstein D. Beule I.K. Na August 01, 2015 in Mol Oncol Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma F. Oden S.F. Marino J. Brand S. Scheu C. Kriegel D. Olal A. Takvorian J. Westermann B. Yilmaz M. Hinz O. Daumke U.E. Höpken G. Müller M. Lipp April 15, 2015 in Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann April 01, 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber April 01, 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein January 15, 2008 in Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert January 01, 1997 in Eur J Immunol Lack of correlation between rejection of tumor cells co-expressing interleukin 2 and B7.1 and vaccine efficiency S. Cayeux G. Richter C. Becker C. Beck A. Aicher A. Pezzutto B. Doerken T. Blankenstein January 01, 1997 in Exp Hematol Successful retroviral mediated transduction of a receptor gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells A. Aicher J. Westermann S. Cayeux G. Willimsky K. Daemen T. Blankenstein W. Uckert B. Doerken A. Pezzutto
October 18, 2021 in Hum Gene Ther Gene therapy "Made in Germany": a historical perspective, analysis of the status quo, and recommendations for action by the German Society for Gene Therapy H. Büning B. Fehse Z. Ivics S. Kochanek U. Koehl C. Kupatt C. Mussolino D.M. Nettelbeck A. Schambach W. Uckert E. Wagner T. Cathomen
June 15, 2021 in Int J Cancer Long-term in vitro expansion ensures increased yield of central memory T cells as perspective for manufacturing challenges S. Herda A. Heimann B. Obermayer E. Ciraolo S. Althoff J. Ruß C. Grunert A. Busse L. Bullinger A. Pezzutto T. Blankenstein D. Beule I.K. Na
August 01, 2015 in Mol Oncol Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma F. Oden S.F. Marino J. Brand S. Scheu C. Kriegel D. Olal A. Takvorian J. Westermann B. Yilmaz M. Hinz O. Daumke U.E. Höpken G. Müller M. Lipp
April 15, 2015 in Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann
April 01, 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
April 01, 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
January 15, 2008 in Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert
January 01, 1997 in Eur J Immunol Lack of correlation between rejection of tumor cells co-expressing interleukin 2 and B7.1 and vaccine efficiency S. Cayeux G. Richter C. Becker C. Beck A. Aicher A. Pezzutto B. Doerken T. Blankenstein
January 01, 1997 in Exp Hematol Successful retroviral mediated transduction of a receptor gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells A. Aicher J. Westermann S. Cayeux G. Willimsky K. Daemen T. Blankenstein W. Uckert B. Doerken A. Pezzutto
